Recor Medical launches Paradise Ultrasound Renal Denervation System in US
Recor Medical, Inc., and its parent company, Otsuka Medical Devices Co., Ltd., have announced the first commercial uses of the Paradise Ultrasound Renal Denervation (uRDN) ... Read More
FDA approves Recor Medical’s Paradise Ultrasound RDN System for hypertension treatment
The U.S. Food and Drug Administration (FDA) has granted approval to Recor Medical, Inc. and its parent company, Otsuka Medical Devices Co., Ltd., for the ... Read More
Roche, Alnylam’s Zilebesiran meets primary endpoint in KARDIA-1 trial
Breaking news in the world of hypertension treatment, Roche and Alnylam Pharmaceuticals have announced the success of their Phase 2 study KARDIA-1. The investigational RNAi ... Read More
BaroPace gets CDSCO approval for RelieveHFpEF-II clinical trial in India
BaroPace Inc., a medical technology company focused on developing pacemaker regulation techniques based on blood pressure, has been granted approval by the Central Drugs Standard ... Read More
FDA greenlights Granules India’s Metoprolol Succinate ER tablets
Granules India Limited announced its receipt of US Food and Drug Administration (FDA) approval for its Abbreviated New Drug Application (ANDA) of Metoprolol Succinate Extended-Release ... Read More
AstraZeneca to acquire US biopharma company CinCor Pharma for $1.8bn
AstraZeneca has agreed to acquire CinCor Pharma for a transaction value of around $1.8 billion, which includes an upfront cash payment of about $1.3 billion, ... Read More
Zydus Lifesciences gets FDA final approval for BP drug generic version
Zydus Lifesciences (previously Cadila Healthcare) has secured final approval for Bisoprolol Fumarate and Hydrochlorothiazide tablets USP, 2.5 mg/6.25 mg, 5 mg/6.25 mg, 10 mg/6.25 mg ... Read More
Zydus Lifesciences wins final FDA approval for pulmonary hypertension drug
Zydus Lifesciences Limited (previously Cadila Healthcare Limited) has bagged final approval for Sildenafil for Oral Suspension USP 10 mg/ml, its generic for Revatio, from the ... Read More
AstraZeneca to sell five hypertension drugs to Atnahs Pharma
AstraZeneca has signed a deal valued at about $390 million with Atnahs Pharma, a portfolio company of Triton Fund V, to sell five of its ... Read More
Consumption of berry juice helps in lowering blood pressure
According to the research, it is revealed that consuming berry juice for long term can benefit hypertension patients to lower blood pressure. The study also ... Read More